ARCHIVES

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

This article is from The Cancer Letter archive.

Vol. 02 No. 46 | November 12, 1976

Download PDF Visit The Full Archive

Related Articles

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

DCE Advisors OK Concepts for Registry, Grants In Breast Cancer

June 25, 1993

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991

NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting

September 12, 1997